Skip to main content
Log in

Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Aim

To perform a systematic review and meta-analysis of the effectiveness and complications of BRTO for gastric varices.

Materials and Methods

A systematic review was performed to identify relevant articles. Inclusion criteria were applied to select studies with at least ten patients with acute bleeding or at-risk gastric varices treated with BRTO. Meta-analysis with random effects model was performed to calculate data for immediate technical success, clinical success, and complications.

Results

A total of 1,016 Patients from 24 studies met inclusion criteria. Technical success rate for BRTO was 96.4 % (95 % CI 93.7, 98.3 %; Q = 3,269.26, p < 0.01, I 2 = 99.39 %). Clinical success (defined as no recurrence or rebleed of gastric varices, or complete obliteration of varices on subsequent imaging) rate was 97.3 % (95 % CI 95.2, 98.8 %; Q = 3,105.91, p < 0.01, I 2 = 99.29 %). Major complication rate was 2.6 % (95 % CI 1.1, 4.6 %; Q = 3,348.98, p < 0.01, I 2 = 99.34 %). Esophageal variceal recurrence rate was 33.3 % (95 % CI 24.6, 42.6 %; Q = 7,291.75, p < 0.01, I 2 = 99.74 %).

Conclusion

BRTO is safe and efficacious for gastric varices, and current best evidence suggests that BRTO could be considered as therapy for patients with gastric varices.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology. 1988;95:434–440.

    CAS  PubMed  Google Scholar 

  2. Hong CH, Kim HJ, Park JH, et al. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 2009;24:372–378.

    Article  PubMed  Google Scholar 

  3. Saad WE, Darcy MD. Transjugular Intrahepatic Portosystemic Shunt (TIPS) versus Balloon-occluded Retrograde Transvenous Obliteration (BRTO) for the Management of Gastric Varices. Semin Intervent Radiol. 2011;28:339–349.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol. 2003;4:109–116.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Jalan R, Hayes P. Reply to: Management of gastric fundal varices associated with a gastrorenal shunt. Gut. 2000;46:578–581.

  6. Sabri SS, Swee W, Turba UC, et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vascular Inter Radiol. 2011;22:309–316; quiz 16.

  7. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996;11:51–58.

    Article  CAS  PubMed  Google Scholar 

  8. Saad WE, Sabri SS. Balloon-occluded Retrograde Transvenous Obliteration (BRTO): technical Results and Outcomes. Semin Intervent Radiol. 2011;28:333–338.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Bellary SV, Isaacs P. Disseminated intravascular coagulation (DIC) after endoscopic injection sclerotherapy with ethanolamine oleate. Endoscopy. 1990;22:151.

    Article  CAS  PubMed  Google Scholar 

  10. Hashizume M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet. 1988;2:340–341.

    Article  CAS  PubMed  Google Scholar 

  11. Hirota S, Matsumoto S, Tomita M, Sako M, Kono M. Retrograde transvenous obliteration of gastric varices. Radiology. 1999;211:349–356.

    Article  CAS  PubMed  Google Scholar 

  12. Lee JY, Moon SH, Lee SM, et al. A case of noncardiogenic pulmonary edema by ethanolamine oleate. Korean J Intern Med. 1994;9:125–127.

    CAS  PubMed  Google Scholar 

  13. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery. 2001;129:414–420.

    Article  CAS  PubMed  Google Scholar 

  14. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. J Am Med Assoc. 2000;283:2008–2012.

    Article  CAS  Google Scholar 

  15. Staunton M. Evidence-based radiology: steps 1 and 2–asking answerable questions and searching for evidence. Radiology. 2007;242:23–31.

    Article  PubMed  Google Scholar 

  16. Halligan S, Altman DG. Evidence-based practice in radiology: steps 3 and 4–appraise and apply systematic reviews and meta-analyses. Radiology. 2007;243:13–27.

    Article  PubMed  Google Scholar 

  17. Saad WE, Nicholson D, Koizumi J. Inventory used for balloon-occluded retrograde (BRTO) and antegrade (BATO) transvenous obliteration: sclerosants and balloon occlusion devices. Tech Vasc Interv Radiol. 2012;15:226–240.

    Article  PubMed  Google Scholar 

  18. Kumamoto M, Toyonaga A, Inoue H, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol. 2010;25:1129–1135.

    Article  PubMed  Google Scholar 

  19. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199–S202.

    Article  PubMed  Google Scholar 

  20. Ebell MH, Siwek J, Weiss BD, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Family Pract. 2004;17:59–67.

    Article  Google Scholar 

  21. Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann LV. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol. 2009;20:1431–1440.

    Article  PubMed  Google Scholar 

  22. Koito K, Namieno T, Nagakawa T, Morita K. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. Am J Roentgenol. 1996;167:1317–1320.

    Article  CAS  Google Scholar 

  23. Matsumoto A, Hamamoto N, Nomura T, et al. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices. Am J Gastroenterol. 1999;94:643–649.

    Article  CAS  PubMed  Google Scholar 

  24. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001;12:327–336.

    Article  CAS  PubMed  Google Scholar 

  25. Ninoi T, Nishida N, Kaminou T, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. Am J Roentgenol. 2005;184:1340–1346.

    Article  Google Scholar 

  26. Takuma Y, Nouso K, Makino Y, Saito S, Shiratori Y. Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2005;3:1245–1252.

    Article  PubMed  Google Scholar 

  27. Arai H, Abe T, Takagi H, Mori M. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol. 2006;12:3866–3873.

    PubMed Central  PubMed  Google Scholar 

  28. Cho SK, Shin SW, Lee IH, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. Am J Roentgenol. 2007;189:W365–W372.

    Article  Google Scholar 

  29. Hiraga N, Aikata H, Takaki S, et al. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol. 2007;42:663–672.

    Article  PubMed  Google Scholar 

  30. Akahoshi T, Hashizume M, Tomikawa M, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol. 2008;23:1702–1709.

    Article  PubMed  Google Scholar 

  31. Chikamori F, Kuniyoshi N, Kawashima T, Takase Y. Gastric varices with gastrorenal shunt: combined therapy using transjugular retrograde obliteration and partial splenic embolization. Am J Roentgenol. 2008;191:555–559.

    Article  Google Scholar 

  32. Nakamura S, Torii N, Yatsuji S, et al. Long-term follow up of esophageal varices after balloon-occluded retrograde transvenous obliteration for gastric varices. Hepatol Res. 2008;38:340–347.

    Article  PubMed  Google Scholar 

  33. Maruyama H, Okugawa H, Kobayashi S, Yoshizumi H, Yokosuka O. Pre-treatment hemodynamic features involved with long-term survival of cirrhotic patients after embolization of gastric fundal varices. Eur J Radiol. 2010;75:e32–e37.

    Article  PubMed  Google Scholar 

  34. Katoh K, Sone M, Hirose A, Inoue Y, Fujino Y, Onodera M. Balloon-occluded retrograde transvenous obliteration for gastric varices: the relationship between the clinical outcome and gastrorenal shunt occlusion. BMC Med Imaging. 2010;10:2.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Choi SY, Won JY, Kim KA. Lee do Y, Lee KH. Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO). Eur Radiol. 2011;21:122–129.

    Article  PubMed  Google Scholar 

  36. Takaji R, Kiyosue H, Matsumoto S, et al. Partial thrombosis of gastric varices after balloon-occluded retrograde transvenous obliteration: CT findings and endoscopic correlation. Am J Roentgenol. 2011;196:686–691.

    Article  Google Scholar 

  37. Uehara H, Akahoshi T, Tomikawa M, et al. Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient. J Gastroenterol Hepatol. 2012;27:137–141.

    Article  PubMed  Google Scholar 

  38. Koizumi J, Hashimoto T, Myojin K, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: use of CT-guided foam sclerotherapy to optimize technique. Am J Roentgenol. 2012;199:200–207.

    Article  Google Scholar 

  39. Sonomura T, Ono W, Sato M, et al. Three benefits of microcatheters for retrograde transvenous obliteration of gastric varices. World J Gastroenterol. 2012;18:1373–1378.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Watanabe M, Shiozawa K, Ikehara T, et al. Short-term effects and early complications of balloon-occluded retrograde transvenous obliteration for gastric varices. ISRN Gastroenterol. 2012;2012:919371.

    PubMed Central  PubMed  Google Scholar 

  41. Yoshimatsu R, Yamagami T, Tanaka O, et al. Development of thrombus in a systemic vein after balloon-occluded retrograde transvenous obliteration of gastric varices. Korean J Radiol. 2012;13:324–331.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Biecker E. Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol. 2013;19:5035–5050.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Yoshida H, Mamada Y, Taniai N, et al. Risk factors for bleeding esophagogastric varices. J Nippon Med School = Nippon Ika Daigaku Zasshi. 2013;80:252–259.

    Article  Google Scholar 

  44. Triantafyllou M, Stanley AJ. Update on gastric varices. World J Gastrointest Endosc. 2014;6:168–175.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Choi YS, Lee JH, Sinn DH, et al. Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices. J Clin Gastroenterol. 2008;42:974–979.

    Article  PubMed  Google Scholar 

  46. Gwon DI, Ko GY, Yoon HK, et al. Gastric Varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge-assisted retrograde transvenous obliteration–a primary report. Radiology. 2013;268:281–287.

  47. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Combination treatment of transjugular retrograde obliteration and endoscopic embolization for portosystemic encephalopathy with esophageal varices. Hepatogastroenterology. 2004;51:1379–1381.

    PubMed  Google Scholar 

  48. Wallace MJ, Madoff DC. Transjugular intrahepatic portosystemic shunts in patients with hepatic malignancy. Semin Intervent Radiol. 2005;22:309–315.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes. Semin Intervent Radiol. 2012;29:118–128.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward Wolfgang Lee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, J.K., Saab, S., Kee, S.T. et al. Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis. Dig Dis Sci 60, 1543–1553 (2015). https://doi.org/10.1007/s10620-014-3485-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-014-3485-8

Keywords

Navigation